NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Loma Therapeutics

Loma Therapeutics

Private
CopenhagenHealthcare & Life Scienceshttps://lomatherapeutics.com/

Last Round

Grant

Jun 1, 2026

Total Funding Raised

$3.65M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Loma Therapeutics is a biotechnology company developing a targeted viral-vector immunotherapy for HPV-induced cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

viral-vector immunotherapyHPV-induced canceroncologycancer vaccinepreclinical researchantigen-delivery platformT-cell therapyhuman papillomavirusHPVbiotech drug discoverytranslational researchimmunogenicity studyex vivo assaysbiotech licensingimmuno-oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Loma Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Loma Therapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Loma Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 1, 2026
GrantJun 26, 2025
Convertible DebtSep 1, 2024
GrantSep 1, 2024
AcceleratorSep 1, 2023

Key People

Founding team and executive leadership

Ditte Boilesen

CEO, CSO and co-founder

Founding Team

Stephanie Holstein-Rønsbo

Chief Operating Officer

Executive Team

Loma Therapeutics Investors

Notable investors and investment history

Loma Therapeutics investors
InvestorRounds
Innovation Fund DenmarkGrant
European CommissionGrant
BioInnovation InstituteAccelerator, Convertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2026

    $724K grant from Innovation Fund Denmark

Loma Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Loma Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Loma Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Employee Range8
Year Founded2023
Last FundingJun 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.